Tip Cards

The IMF Tip Cards cover key myeloma treatment and care issues in a concise manner and are designed for you to carry with you as consistent references.

What is Multiple Myeloma?
July 17, 2018

Gain a basic understanding of myeloma —what the disease is, its incidence, its symptoms, and how to get support. 


Adherence to Oral Cancer Therapy
October 15, 2018

Studies have demonstrated that lack of adherence to a treatment plan is a major reason for treatment failure

Darzalex® (daratumumab)
July 03, 2018

This laboratory-made monoclonal antibody targets a specific protein on the surface of myeloma cells.


Early Warning Signs
July 03, 2018

Early diagnosis is key to achieving best outcomes for patients

Empliciti® (elotuzumab)
September 05, 2018

This immunostimulatory monoclonal antibody is used in combination with lenalidomide + dexamethasone.

Farydak® (panobinostat)
October 15, 2018

This histone deacetylase inhibitor is approved to treat myeloma in combination with bortezomib + dexamethasone.


November 13, 2018

These blood tests measure the concentration of free kappa and free lambda light chains (Freelite®) and the concentration of immunoglobulin pairs (Hevylite®).

Kyprolis® (carfilzomib)
July 03, 2018

This proteasome inhibitor is used in combination with dexamethasone, or with lenalidomide + dexamethasone.


Myeloma and the Immune System
May 16, 2018

Myeloma suppresses the immune system, reducing the number of normal antibodies and affecting all the cells that patrol for and attack abnormal cells.


Myeloma Matrix 2.0: Smart Search
July 03, 2018

The IMF’s Myeloma Matrix, designed to track drugs in development for myeloma, is now Myeloma Matrix 2.0: Smart Search, a clinical trial search tool developed by the IMF and Smart Patients.

Ninlaro® (ixazomib)
July 03, 2018

This proteasome inhibitor is indicated for patients with myeloma who have received at least one prior therapy.


Pomalyst® (pomalidomide)
July 03, 2018

This immunomodulatory drug is indicated in combination with dexamethasone for myeloma patients who have received at least two prior therapies.


Your Healthcare Records
September 04, 2018

Protecting yourself and your medical information